112 completed, 39 unknown, 21 recruiting, 15 terminated. 207 Phase 1, 90 Phase 2.
Follow Diabetes Complications: new trials by email Literature Review of Diabetes Complications trials Research Report on Diabetes Complications
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Placental Cells for Diabetic Foot Ulcers Placenta Stem Cells - Diabetic Foot Ulcer | Phase 1 | Not yet recruiting | Wake Forest University Health Sciences | 12 | 2027-03-01 | 2026-10-23 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PAL-119 in Healthy Volunteers and Adult Participants With Type 1 or Type 2 Diabetes PAL-119, Placebo - Healthy Volunteers and Diabetes Participants | Phase 1 / Phase 2 | Not yet recruiting | Paulex Bio Inc. | 147 | 2026-11-01 | 2026-10-28 |
| Mesenchymal Stem Cells for Chronic Kidney Diseases 0.9% sodium chloride, MSCs - Kidney Disease, Chronic, Diabetic Kidney Disease (DKD) | Phase 1 / Phase 2 | Not yet recruiting | The First Affiliated Hospital of Air Force Medical University | 32 | 2026-11-01 | 2026-11-16 |
| Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Diabetic Foot Ulcers PRFM, Standard of Care (SoC) - Diabetic Foot Ulcer (DFU), Ulcer | Phase 1 / Phase 2 | Not yet recruiting | Tiger Biosciences, LLC. | 55 | 2026-09-01 | 2026-09-25 |
| Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus Topical anti-Staphylococcus bacteriophage therapy, Topical placebo corresponding to anti-Staphylococcus bacteriophage therapy - Diabetic Foot, Staphylococcal Infections | Phase 1 / Phase 2 | Not yet recruiting | Centre Hospitalier Universitaire de Nīmes | 60 | 2026-09-01 | 2026-03-20 |
| Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema Octreotide (drug), Placebo - Diabetic Macular Edema | Phase 1 | Withdrawn | University of Alabama at Birmingham | 2026-08-31 | 2026-10-13 | |
| Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial Umbilical Cord Mesenchymal Stem Cells - Diabetic Nephropathy Type 2 | Phase 1 / Phase 2 | Recruiting | PT. Prodia Stem Cell Indonesia | 10 | 2026-07-01 | 2026-02-09 |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy RO7663498 - Diabetic Retinopathy | Phase 1 | Recruiting | Hoffmann-La Roche | 30 | 2026-06-18 | 2026-11-09 |
| Controlled Trial to Evaluate the Safety and Efficacy of CYWC628 (Human Dermal Fibroblast Spheroids) for the Treatment of Refractory Diabetic Foot Ulcers Compared With Standard of Care Standard of Care (SOC), SoC + Low dose CYWC628, SoC + High dose CYWC628 - Diabetic Foot Ulcer (DFU) | Phase 1 / Phase 2 | Recruiting | FibroBiologics | 120 | 2026-06-01 | 2026-08-26 |
| Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease MTX-439, Placebo - Healthy Adult Participants, Diabetic Kidney Disease | Phase 1 | Recruiting | Mediar Therapeutics | 88 | 2026-05-19 | 2026-06-29 |
| Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study Cannabidiol (CBD) oral solution, Full-Spectrum CBD hemp extract oral solution, Placebo in MCT oil oral solution - Diabetic Peripheral Neuropathic Pain (DPN), Diabetic Neuropathies | Phase 1 / Phase 2 | Recruiting | Florida A&M University | 20 | 2026-04-02 | 2026-04-29 |
| Human Umbilical Cord Mesenchymal Stem Cell Injection for Diabetic Nephropathy UC-MSCs, Placebo - Diabetic Nephropathy | Phase 1 | Recruiting | Tongji Hospital | 15 | 2026-03-25 | 2026-09-16 |
| Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue an allogenic cell-based product, containing living human bone marrow-derived mesenchymal stem cells (MSCs) and MSCs differentiated into adipocytes on a porous chitosan-gelatin matrix, Standard of Care of Diabetic Foot Ulcers - Diabetic Foot Ulcer (DFU), Granulation of Chronic Diabetic Wounds | Phase 1 | Recruiting | Ayu, Inc. | 24 | 2026-03-11 | 2026-09-02 |
| Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes Arginine hydrochloride, Sodium Chloride 0.9% - Diabetes (DM), Diabetic Ketoacidosis | Phase 1 / Phase 2 | Recruiting | David K Carroll | 60 | 2025-12-19 | 2026-02-12 |
| Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers ELU42 Topical Spray - Diabetic Foot Ulcer, Wagner Grade 1 - 2 | Phase 1 / Phase 2 | Recruiting | Eluciderm Inc | 15 | 2025-11-10 | 2026-02-12 |
| Air-Dried Human Amniotic Membrane Terminally Sterilized by Gamma Irradiation for Multidisciplinary Clinical Application Air-Dried Human Amniotic Membrane (AD-hAM) - Diabetic Foot Ulcer (DFU), Ocular Disorder | Phase 1 | Active not recruiting | Libyan Center for Biotechnology Research | 2 | 2025-11-01 | 2026-06-29 |
| CGM-Guided Acarbose for Painful Diabetic Neuropathy Acarbose 50 mg, Placebo - Diabetes, Diabetes Complications | Phase 1 | Completed | Shifa International Hospital | 170 | 2025-09-01 | 2026-03-03 |
| Safety and Preliminary Efficacy of TrophiPatch, an Adipose-Derived Stromal Cell Patch for Chronic Leg Ulcers TrophiPatch: allogeneic adipose-derived stromal cell patch - Diabetic Foot Ulcer (DFU), Venous Leg Ulcer (VLU) | Phase 1 / Phase 2 | Recruiting | Nicolò Brembilla | 18 | 2025-07-01 | 2025-07-02 |
| A Study to Investigate Safety, Tolerability, PK, and PD of AZD4248 in Healthy Participants, Participants With CKD and Type 2 Diabetes, Assess Home Measurements of Creatinine in a Non-Interventional Cohort, and Assess the Effect of AZD4248 on the PK of Midazolam and Metformin in Healthy Participants AZD4248, Placebo, Midazolam - Chronic Kidney Disease | Phase 1 | Recruiting | AstraZeneca | 192 | 2025-06-09 | 2026-11-12 |
| Effect of Feldenkrais Method in Enhancing Postural Control for Patients with Diabetic Polyneuropathy The Feldenkrais-based intervention, conventional balance training program - Diabetic Polyneuropathy | Phase 1 | Enrolling by invitation | Cairo University | 24 | 2025-03-30 | 2025-04-01 |
Showing 20 of 207. Sign in to see all of them.
Diabetic Foot (85) · Diabetic Retinopathy (48) · Diabetes Mellitus (44) · Diabetic Nephropathies (38) · Diabetic Neuropathies (26) · Diabetes Mellitus, Type 1 (12) · Diabetes Mellitus, Type 2 (11) · Foot Ulcer (9) · Macular Edema (9) · Kidney Diseases (8) · Renal Insufficiency, Chronic (8) · Macular Degeneration (7) · Peripheral Vascular Diseases (7) · Retinal Diseases (7)
Endocrine System Diseases (205) · Diabetes Mellitus (163) · Cardiovascular Diseases (136) · Vascular Diseases (134) · Diabetic Angiopathies (132) · Skin and Connective Tissue Diseases (87) · Diabetic Neuropathies (85) · Skin Diseases (85) · Skin Ulcer (83) · Leg Ulcer (82) · Foot Ulcer (76) · Glucose Metabolism Disorders (55) · Nutritional and Metabolic Diseases (55) · Metabolic Diseases (54)
Standard of Care (11) · Sodium Chloride (6) · Triamcinolone Acetonide (5) · Ranibizumab (4) · Drug Evaluation (3) · Iohexol (3) · Metformin (3) · Saline Solution (3) · p-Aminohippuric Acid (3) · Bevacizumab (2) · Injections (2) · Laser Therapy (2) · Lidocaine (2) · Sirolimus (2) · aflibercept (2)
National Eye Institute (NEI) (5) · Boehringer Ingelheim (4) · University of Sao Paulo (4) · Jie Shen (3) · University of Colorado, Denver (3) · GL Pharm Tech Corporation (2) · Goldfinch Bio, Inc. (2) · Hadassah Medical Organization (2) · Hanan Jafar (2) · Heidelberg University (2) · NOxy Health Products, LLC (2) · National Taiwan University Hospital (2) · Sheba Medical Center (2) · South China Research Center for Stem Cell and Regenerative Medicine (2) · Stratatech, a Mallinckrodt Company (2)
United States (85) · China (16) · Germany (10) · Israel (10) · United Kingdom (9) · Australia (7) · South Korea (7) · Taiwan (6) · Brazil (5) · India (4) · Iran (4) · Spain (4) · Denmark (3) · Egypt (3) · France (3)
Jie Shen (3) · Masaomi Nangaku, Professor (2) · Min-Gul Kim, Ph.D. (2) · Petter Bjornstad, MD (2) · Wei-Li Chen, MD, PhD (2) · Abdalla Awidi, MD (1) · Abdallah Awidi, MD (1) · Albert Sotto, MD, PhD (1) · Alireza Goodarzi, MSc (1) · Allan H Ropper, M.D. (1) · Aman Shah Abdul Majid, Ph.D. (1) · Ambarish Pandey, MD, MSCS (1)
PMID 17342504, PMID 19211094, PMID 20579630, PMID 21185118, PMID 21567211, PMID 22289660, PMID 22446172, PMID 22457045, PMID 22961573, PMID 23639598, PMID 25272318, PMID 25491299, PMID 26054585, PMID 27743903, PMID 28133924, PMID 29631615, PMID 29854007, PMID 30825073, PMID 30917698, PMID 32737116, PMID 33011075, PMID 33407796, PMID 33504262, PMID 34052927, PMID 34218718, PMID 34398099, PMID 34586227, PMID 35507146, PMID 35978329, PMID 36064604, PMID 36623423, PMID 37395169, PMID 37560967, PMID 37783947, PMID 38497241, PMID 39727944, PMID 39727950, PMID 39727989, PMID 39740667, PMID 39838970, PMID 39852146, PMID 40009460, PMID 40333016, PMID 40695570, PMID 41141513, PMID 41708511, PMID 41805697, PMID 42246764
2015 (2), 2016 (2), 2018 (2), 2019 (2), 2005 (1), 2008 (1), 2014 (1), 2017 (1), K23HL159292 (1), R01DK063017 (1), R01DK126837 (1), R01EY031315 (1), R43DK088634 (1), R44AR046154 (1), R44DK069924 (1)